Alkermes PLC (ALKS) intrinsic value & 10-year financials

Alkermes PLC (ALKS) has a Graham intrinsic value of $29.93 per share. At $41.22 on Oct 17, 2026, the stock trades 38% above that value. Over the last 10 fiscal years revenue grew 7.9% a year to $1.5B, with an average return on invested capital of 0.9%.

Graham intrinsic value
$29.93
Share price (Oct 17, 2026)
$41.22
Price vs Graham value
38% above
Market cap
$7.0B
Revenue (FY2025)
$1.5B
Revenue growth (10-yr CAGR)
7.9%
ROIC (10-yr avg)
0.9%
Free cash flow (FY2025)
$480.3M

ALKS 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $1.5B $241.7M $1.43 $480.3M 17.2% 15.4%
FY2024 $1.6B $367.1M $2.17 $405.6M 27.0% 29.9%
FY2023 $1.7B $355.8M $2.10 $353.3M 24.9% 37.1%
FY2022 $1.1B -$158.3M -$0.97 -$17.2M -12.8% -11.7%
FY2021 $1.2B -$48.2M -$0.30 $73.7M -2.5% -2.5%
FY2020 $1.0B -$110.9M -$0.70 $40.6M -10.8% -9.6%
FY2019 $1.2B -$196.6M — -$18.9M -15.0% -14.9%
FY2018 $1.1B -$139.3M — $29.9M -9.1% -8.0%
FY2017 $903.4M -$157.9M — -$32.1M -16.4% -11.4%
FY2016 $745.7M -$208.4M — -$107.5M -28.0% -15.5%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Alkermes plc. has demonstrated mature, steady growth, with revenue compounding at 7.9% annually over the past decade.

Alkermes plc. has historically struggled to out-earn its cost of capital, averaging just 0.9% ROIC.

Alkermes plc. has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, Alkermes plc. is modeled at 7.9% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $29.93 per share.

ALKS stock: frequently asked questions

What is the intrinsic value of Alkermes PLC (ALKS) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 7.9% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, ALKS's intrinsic value is about $29.93 per share.

Is ALKS stock undervalued?

At $41.22 (close on Oct 17, 2026), ALKS trades 38% above its Graham value of $29.93. On Graham's terms the shares look fully priced. A formula is a starting point for research, not a recommendation.

How fast has Alkermes PLC grown?

Revenue went from $745.7M in fiscal 2016 to $1.5B in fiscal 2025, a compound annual growth rate of 7.9%. Net income was $241.7M in fiscal 2025.

Does Alkermes PLC generate free cash flow?

Alkermes PLC generated $480.3M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 6 of the last 10 reported years.

What is ALKS's return on invested capital?

Average ROIC over the last 10 fiscal years was 0.9%, and average return on equity was -1.5%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this ALKS data come from?

From Alkermes PLC's annual 10-K filings on SEC EDGAR, most recently filed Jul 28, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks